Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 175   

Articles published

GSK 1,548.95 -8.05 (-0.52%)
price chart
Is GlaxoSmithKline plc The World's Most Undervalued Company?
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is cheap. Really cheap, there is no other way of putting it. Indeed, Glaxo currently trades at a valuation lower than all of its international peers within the biotechnology sector.
GSK Takes Another Hit As News Of 2001 Bribery Scandal Resurfaces  Bidness Etc
China to hold public trial of foreign couple who worked for GSK  TODAYonline
Related articles »  
The Rising Pound Will Hit GlaxoSmithKline plc, BHP Billiton plc, ARM Holdings ...
A strong currency is a sign of global punching power, but it can leave investors on the ropes. Sterling's resurgence has dealt a few body blows to the FTSE 100, whose constituents generate more than three-quarters of their earnings overseas.
Related articles »  
GlaxoSmithKline plc Given Hold Rating at Panmure Gordon (GSK)
GlaxoSmithKline plc (ADR) logo Panmure Gordon reiterated their hold rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research report sent to investors on Friday morning.
GlaxoSmithKline plc Stock Rating Reaffirmed by Credit Suisse (GSK)  Intercooler
Related articles »  
After Another Shire PLC Bid, Could AstraZeneca plc Or GlaxoSmithKline plc Be ...
shire With Abbvie's �53.20 per share offer receiving a 'thumbs up' from the board of Shire (LSE: SHP), it means that shares in the healthcare stock have risen by 75% during the course of 2014.
Related articles »  
Eyes Down For GlaxoSmithKline plc Results
gsk GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been overshadowed a bit of late by takeover attempts at rival AstraZeneca, and its share price has lagged a little - it's been see-sawing all year and is down around 8% over the past 12 months, ...
3 Things That Say GlaxoSmithKline plc Is A Buy
Well, having the company in the Fool's Beginners' Portfolio, reckon I can say it's cheap! Here are three things that would make me add GlaxoSmithKline if it wasn't already there: 1. Fundamentals. Quality companies are often rated on higher-than-average ...
Is Hikma Pharmaceuticals Plc A Better Buy Than GlaxoSmithKline plc Or Shire ...
shire It's been a great first half of 2014 for investors in Hikma (LSE: HIK), with the pharmaceutical company seeing its share price rise by 47%, while the FTSE 100 is up just 1.5%.
Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And ...
Meanwhile, stable mate GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) continues to deal with negative publicity surrounding its Chinese operations, thereby holding its share price back throughout 2014 so that it is now down 1% for the year.
Related articles »  
GlaxoSmithKline plc's �Underperform� Rating Reaffirmed at Credit Suisse (GSK)
Shares of GlaxoSmithKline plc (NYSE:GSK) traded up 1.21% during mid-day trading on Friday, hitting $53.72. 1,973,737 shares of the company's stock traded hands.
GlaxoSmithKline plc Receives Consensus Rating of �Hold� from Analysts (NYSE ...  Mideast Time
GlaxoSmithKline plc's "Hold" Rating Reaffirmed at Panmure ...  Watch List News (press release)
Related articles »  
Why The Chinese Corruption Saga Makes GlaxoSmithKline plc A Dicey Pick
Make no mistake: GlaxoSmithKline's ongoing bribery saga in China shows no signs of disappearing any time soon. Allegations initially emerged in June last year that the company was operating a vast slush fund to bribe doctors with cash and other ...
GSK's Mark Reilly In Another Scandal, This Time Over Sex Tape  Bidness Etc
China says GSK-linked trial being handled according to law  Reuters UK
Related articles »